急性心肌梗死溶栓和药物治疗的临床疗效分析

Clinical effect analysis of thrombolytic medication for AMI

目的观察急性心肌梗死患者进行溶栓和药物治疗的临床效果,评价其用药安全性和临床应用价值。方法选取笔者所在医院2010年8月～2011年8月收治的急性心肌梗死患者126例,随机分为对照组与观察组,每组各63例,其中对照组患者采用常规药物治疗,观察组患者采用溶栓药物治疗,观察两组患者临床疗效及急性期心脏事件的发生情况。结果观察组患者治疗后冠状动脉再通率明显高于对照组,患者死亡率低于对照组,而出血和心源性休克等并发症发生率低于对照组,两组比较差异有统计学意义(P<0.05)。结论尿激酶静脉溶栓治疗急性心肌梗死效果显著,可有效促进患者心肌功能的恢复,明显提高抢救成功率,值得临床推广和应用。

Objective To analyze the clinical effect of thrombolytic medication for AMI in order to assess its safety and clinical application value.Methods 126 cases of AMI patients were chosen for the research during the time from August 2010 to August 2011 in hospital.63 cases of patients in the contrast group were treated by routine medication for their treatment and the other 63 patients in the treatment group were treated by thrombolytic medication.Compared with the clinical effects and the emergency situation frequency during their treatment.Results The coronary reperfusion of the patients in the treatment group was obviously higher than that of the contrast group and its mortality and complication such as hemorrhage.Cardiac shock was lower than that of contrast group.Conclusion The thrombolytic medication treatment has obviously clinical effect for AMI patients.It can effective promote patients＇ myocardial function and increase the success rate of rescue.It should be extended.